Court
– Teva confirmed that it will continue to vigorously defend its Copaxone intellectual property rights. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)...
Hi, what are you looking for?
Jewish Business News
All posts tagged "Copaxone"
Business
– Sales of the multiple sclerosis treatment were down 12% in the second quarter. – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) reported...
Business
– Barclays analyst Douglas Tsao sees the success of double-dose Copaxone as a platform for expansion. – “The mergers and acquisition phenomenon is one...
Business
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today announced that the Company has filed a citizen petition (CP) regarding the approvability of purported generic versions of...
Money
– Teva investors are concerned about competition to the company’s Copaxone medication now that its patent has expired. Due to its failed attempt recently...
Business
– Mylan CEO Heather Bresch: Teva’s suit against the FDA was simply a desperate, last minute tactic. – – “We continue to see no...
Court
– The US Supreme Court has in effect allowed generic versions of the MS drug from next month. – – Teva Pharmaceutical Industries Ltd. TEVATEVA (NYSE: ;...
Court
– – The US Supreme Court has agreed to hear an appeal by Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) over the expiry of its patents for...
StartUps
– Synthon says its Phase III clinical trial of glatiramer acetate found an equivalent efficacy and safety profile to Copaxone. – – Dutch drug...
Blogs
– (Was Originally Published at Knowlegde@Wharton) – On 11 February, when Erez Vigodman stepped into the corner office at Teva Pharmaceutical Industries, he didn’t come...